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ABSTRACT
This project investigated: 1) the contribution of pharmaceutically active compounds
(PhACs) from residential and hospital effluent sources, 2) resultant concentrations of
PhACs in the Albuquerque Southside Water Reclamation Plant (SWRP) raw influent and
treated effluent, and 3) concentrations of PhACs in the Rio Grande, which receives
SWRP effluent. PhACs present in surface waters have been shown to adversely impact
organisms (Jobling et al., 1998) and, in the case of antibiotics, perhaps increase resistance
to these drugs (Ash, 1999; Eichorst, 1999; Guardabassi et al, 1998; Sternes, 1999).

In this study, ten sample sites were identified and samples collected and analyzed for the
presence of 39 PhACs, consisting of 29 non-antibiotic PhACs and 10 antibiotics. The
Scientific Laboratory Division of the New Mexico Department of Health (SLD)
conducted all analyses. Antibiotic analyses involved solid phase extraction, high
performance liquid chromatography, and tandem mass spectrometry while the nonantibiotic PhACs were analyzed using liquid-liquid extraction, gas chromatography, and
tandem mass spectrometry.

Six antibiotics (sulfamethoxazole, trimethoprim, ciprofloxacin, ofloxacin, lincomycin,
and penicillin G) and caffeine were detected in hospital wastewater (300-35,000 ng/l),
while only one antibiotic, ofloxacin, was detected in wastewater from one of the two
residential sites (1,300 ng/l). Three antibiotics: sulfamethoxazole, trimethoprim, and
ofloxacin were present in both SWRP influent and treated effluent in concentrations
ranging from 110 ng/l to 470 ng/l. However, concentrations in the treated effluent were
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reduced 20 to 77 percent. No PhACs were detected in the Rio Grande sample upstream of
the SWRP discharge, and only one antibiotic, sulfamethoxazole, was detected in the two
Rio Grande samples below SWRP.

These results reveal that most of the PhACs analyzed for were absent or at undetectable
concentrations in wastewater. However, antibiotics, particularly some sulfonamides and
fluoroquinolones, were found at relatively high concentrations in hospital wastewater and
were not completely removed by wastewater treatment. In particular, the sulfonamide
antibiotic, sufamethoxazole, displayed high persistence and was detected at
concentrations of 300 ng/l in the Rio Grande.
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1.0 INTRODUCTION

Pharmaceutically active compounds (PhACs) such as analgesics, anti-convulsants, antidepressants, anti-inflammatories, hormones, and antibiotics can enter municipal and
natural water systems via residential or commercial discharges, including hospital
effluent. Although PhACs are intended to be utilized by the human body, in some
instances as much as 50 to 90 percent of an administered drug may be excreted by the
body in a biologically active form (Raloff, 1998). Wastewater treatment facilities vary in
their ability to remove PhACs. Consequently, PhACs are released into surface waters
where they may adversely impact aquatic organisms (Jobling et al., 1998) and, in the case
of antibiotics, perhaps increase resistance to these drugs (Ash et al., 1999; Eichorst et al.,
1999; Guardabassi et al., 1998; Sternes, 1999 ).

In 2000, the New Mexico Environment Department (NMED) and the Scientific
Laboratory Division of the New Mexico Department of Health (SLD) initiated a study of
PhACs in New Mexico waters. NMED detected a variety of drug residues in 11 of 15
sewage effluent samples and in 4 of 23 surface water samples (McQuillan et al., 2000,
2001, and 2002). Estrogenic hormones were detected in trout and silvery minnow habitats
in the San Juan and Rio Grande rivers respectively (McQuillan et al., 2002), at levels that
have been shown to cause sexual disruption of wild fish in Europe (Jobling et al., 1998).
Antibiotics like those found by NMED in New Mexico sewage effluents (McQuillan,
2002), and in streams worldwide (Heberer et al., 2001; Sedlak and Pinkston, 2001) are of
concern due their possible connection to the development of antibiotic-resistant
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organisms, the potential for disruption of microbial ecology, complications surrounding
development of water reuse technologies, and even increased human health risks
(Daughton and Ternes, 1999; Guardabassi et al., 1998; Huang et al., 2001).

The development of antibiotic-resistant bacteria is an increasing concern. Recent studies
have found widespread antibiotic-resistant bacteria in the Rio Grande (Sternes, 1999), in
several major U.S. rivers (Eichorst et al., 1999), and in wild Canada geese (Ash et al.,
1999). The widespread and often inappropriate administration of antibiotics in livestock,
pets, and humans has been shown to result in the development of antibiotic-resistant
bacteria and is generally accepted to be the primary pathway for proliferation of
antibiotic-resistant bacteria in the environment (Shagum, 2003, personal communication,
unreferenced).

However, there is concern that long-term, low dose concentrations (ng/l-µg/l) of
antibiotics, such as those present in wastewater and surface water, could also result in the
development of antibiotic-resistant organisms. Although there is a paucity of literature
addressing this potential pathway, one study has shown increased prevalence of
antibiotic-resistant Acinetobacter spp. in sewers receiving wastewater effluent from a
hospital and a pharmaceutical plant (Guardabassi et al., 1998). Specifically, sewers
downstream from the hospital displayed an increased prevalence of bacteria resistant to
oxytetracycline, while sewers downstream from the pharmaceutical plant showed an
increased prevalence of bacteria resistant to multiple drugs, including sulfamethoxazole.
The results of this study and in particular, the findings at the pharmaceutical plant, seem
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to lend credence to the concern that antibiotic-resistant bacteria could develop from
environmental exposure to pharmaceuticals. However, although concerning, this study
alone is not sufficient to determine the relative risk. Consequently, while the presence of
antibiotics in wastewater and surface water is discussed widely in the literature as an area
of concern it is also identified as a topic in much need of further investigation.

Additionally, in hospital effluent, ciprofloxacin was detected at levels from 3 µg/l to 87
µg /l (Hartmann et al., 1998). Ciprofloxacin, a fluoroquinolone antibiotic, was shown to
display high genotoxicity at these concentrations. Genotoxic substances are often also
mutagenic and carcinogenic and are therefore especially concerning. Furthermore, the
presence of genotoxic antibiotics in hospital effluent is of particular concern for its
possible connection to proliferation of antibiotic-resistant organisms. Although several
studies have detected the occurrence of antibiotics in hospital effluent (Alder et al., 2003;
Feldmann et al., 2003; Hartmann et al. 1998), little is known about their fate or effects in
the environment (Guardabassi et al, 1998; Hartmann et al. 1998)

This study investigated hospital and residential effluents for their potentially significant
contribution of PhACs to wastewater systems, such as the Albuquerque Southside Water
Reclamation Plant (SWRP). Wastewater effluent has been shown to be a primary
contributor of PhACs to surface water (Daughton and Ternes, 1999). Surface run-off,
mainly from confined animal feed operations, is also a significant contributor of PhACs
to surface water, but is not specifically addressed in this study (Daughton and Ternes,
1999).
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This professional project was conducted in collaboration with NMED and SLD to
investigate: 1) the contribution of PhACs from residential and hospital effluent sources
and, 2) the resultant PhAC concentrations in Albuquerque’s SWRP raw influent, treated
effluent, and in the Rio Grande, which receives SWRP effluent. While it is generally
accepted that hospitals are a primary point source for PhACs in water, there is little
literature documenting the quantities contributed (Hartmann et al., 1998). In fact, the
EPA website identifies the issue of hospital vs. residential contributions of PhACs as one
of its top research needs (Daughton, 2002). Additionally, research indicates that sunlight
can degrade some PhACs, notably fluoroquinolone and tetracycline antibiotics (Buser et
al., 1998; Huang et al., 2001). Given New Mexico’s prevalent sunlight, and wide and
shallow river morphology, this degradation process is of particular significance.

In prior studies, concentrations of PhACs ranging from 1 ng/l to 100 ng/l seemed to
correlate with a region’s population density (Raloff, 1998). Similarly, the highest
concentrations tended to show up in the smallest rivers, where 50 percent of the water
could be sewage treatment effluent (Raloff, 1998). The SWRP effluent is a major
contributor of flow in the Rio Grande and is considered the fifth largest tributary to the
Rio Grande (Stomp, 2003, personal communication, unreferenced).

The City of Albuquerque plans to divert additional Rio Grande water as part of the San
Juan-Chama Diversion Project and Albuquerque Drinking Water Program (City of
Albuquerque, 2003). The diversion of approximately 94,0000 acre-feet/year (af/y) will
occur in Albuquerque north of Paseo del Norte Blvd. and the return flow of
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approximately 47,000 af/y will occur in the Albuquerque South Valley via the SWRP
effluent. Operation of the diversion is only planned for conditions when the river flow is
large, hence although 15 miles of the Rio Grande will have a diminished flow, this
reduction will be small.

Predicting the actual reduction in Rio Grande flow attributed to this change from ground
to surface water diversion is a complicated hydrologic process involving connections
between the river and groundwater aquifers. However, the City of Albuquerque predicts
the effective loss of water in this stretch of the Rio Grande to be only 34,000 af/y, not the
full 94,000 af/y. This prediction is based on the expected contribution of additional water
to the Rio Grande from the surrounding aquifer once groundwater pumping is reduced.

Ultimately, however, flow in the Rio Grande through Albuquerque will be diminished to
some extent while the quantity of SWRP effluent remains the same. Consequently, the
flow contribution from the SWRP effluent will be a higher percentage of total river flow,
resulting in a greater impact to the water quality of the river. (See Appendix A for
calculations of SWRP effluent and Rio Grande flow rates and dilution)

As part of the Albuquerque Drinking Water Program, surface water will be used for
drinking. This raises the questions of whether PhACs might be present in the surface
water to be used and, if present, will treatment techniques be capable of removing them?
Because very little is known about safe allowable limits for drinking water or about the
temporal and spatial fluctuations of PhACs in surface waters, this is a significant concern.
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While previous studies have found no detectable concentrations of PhACs in drinking
water samples in New Mexico (McQuillan, 2000), PhAC have been detected in U.S.
municipal drinking water revealing that at least some conventional treatment processes
are not fully effective in removing all PhACs (Stackelberg et al., 2003). Additionally, the
combined effects of drought and increased diversions could push concentrations of
PhACs to levels of concern.
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2.0 METHODS
2.1 Selection of PhACs
A total of 10 antibiotics and 29 other non-antibiotic PhACs were selected for testing
(Table 1). Selection of PhACs was based on five factors: 1) analytical capabilities of
SLD, 2) data identifying the most commonly prescribed drugs in the US (Table 2) and at
UNM Hospital in Albuquerque, NM (Achusim, 2003, personal communication;
unreferenced), 3) classes of drugs with known and suspected environmental and species
impact (Ash et al., 1999; Eichorst et al., 1999; Jobling et al., 1998; McQuillan et al.,
2002), 4) classes of drugs that persist in aqueous environments and have previously been
detected in wastewater and natural waters (Huang et al., 2001), and 5) PhACs included in
previous NMED studies that will offer a comparison group (McQuillan et al., 2001).

Table 1: PhACs investigated in this study
Drug Class

Non-antibiotic PhACs (29 Total)

Analgesics
AntiConvulsants

propoxyphene (Darvon)

AntiDepressants

phenytoin (Dilantin)
fluoxetine (Prozac), sertraline (Zoloft), amitriptyline, protriptyline,
trimipramine maleate, nortriptyline, desipramine, imipramine, doxepin,
nordoxepin, paroxetine

Antimethyprednisolone, prednisone
Inflammatory
equilin, 17β-estradiol, estrone, 17α-ethynyl estradiol,
Hormones
medroxyprogesterone, megestrol acetate, mestranol, progesterone,
norethindrone, norethynodrel, norgestrel, cholesterol
Other
caffeine, tamoxifen
Antibiotics (10 Total)
Antibiotics

norfloxacin, lincomycin, oxytetracycline HCl, ciprofloxacin, ofloxacin,
trimethoprim, penicillin G. 1/2 – benzathine salt, sulfamethoxazole,
penicillin V potassium salt, tylosin tartrate
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Table 2: Most commonly prescribed drugs in the United States
(McQuillan et al., 2001; RxList, 2003).
Drug Class

Specific Drugs

Analgesics

hydrocodone, ibuprofen, propoxyphene (Darvon), acetaminophen
amoxicillin, azithromycin, cephalexin, ciprofloxacin,
clarithromycin, penicillin VK
diazepam, phenytoin (Dilantin)
fluoxetine (Prozac), paroxetine (Paxil), sertraline (Zoloft),
amitriptyline
amlodipine, digoxin, enalapril, lisinopril, furosemide, diltiazem
thyroxine, estrogen hormones

Antibiotics
Anti-Convulsants
Anti-Depressants
Cardiovascular
Hormones
Lipid Lowering
Agents

atorvastatin, lovastatin, simvastatin

2.2 Selection of Sampling Sites
Locations of sampling sites are presented in Table 3. Sampling sites were selected to
address three primary objectives: 1) investigate point source contributions of PhACs from
hospital and residential sources, 2) determine removal of PhACs by a well run treatment
plant and 3) investigate the occurrence and fate of PhACs in the Rio Grande, upstream
and downstream of SWRP.

Contributions of PhACs from hospital and residential sources to wastewater have not
been well documented (Daughton, 2002). In this study, sample sites 1-5 were selected to
address this issue (Table 3). Hospitals were selected because, while it is generally
accepted that they are a significant point source contributor of PhACs, there is little
literature documenting the quantities contributed (Hartmann et al., 1998). Three hospitals
were selected based on their patient population profiles, ease of accessibility to effluent
pipes, and willingness to participate in study. Two residential sites were selected to
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Table 3: Locations of sampling sites
Site No.

Sample Site Name

Details of Site Location

1

Presbyterian Hospital

2

University Hospital

3

VA Hospital

4

UNM Alvarado Dormitory

5
6

Vista del Rio Assisted
Living/Retirement
Community
SWRP influent

7

SWRP effluent

8

Rio Grande 1

9

Rio Grande 2

10

Rio Grande 3

Hospital effluent at NE corner of Silver and
Oak St. (manhole)
Hospital effluent at NE corner of Lomas Blvd
and hospital entrance road (sewer access)
Hospital effluent under overhang at main
entrance to hospital (manhole)
Dormitory effluent south of Campus Dr. and
west of loading ramp (manhole)
Facility effluent via cleanout pipe located off
north side of building at the edge of the NW
parking lot (clean-out)
City of Albuquerque laboratory official daily
influent sample (called T.P. 2.3 by city)
City of Albuquerque laboratory official daily
effluent sample (called T.P. 2.7 by city)
At Los Calabacitas Arroyo, north of Paseo del
Norte Bridge; upstream of SWRP discharge
Approximately 1.0 mile downstream from
SWRP discharge
Approximately 1.5 miles north of
I-25 interstate bridge; approximately 4.0 miles
downstream from SWRP

represent potential contributions from the population at large. The UNM Alvarado
dormitory was selected to represent a relatively young population, while Vista del Rio
Assisted Living/Retirement Community was selected to represent a more elderly
population. The sample collection times for hospitals were selected based on prior
research showing that concentrations of PhACs in hospital wastewater vary throughout
the day with peaks between 6 a.m. and 10 a.m., and between 6 p.m. and 8 p.m. (Guiliani
et al., 1996; Feldmann, 2003, personal communication; unreferenced). By selecting
collection times during the potentially peak hours of 6 a.m. to 10 a.m., samples were
more likely to contain PhACs.
11

The SWRP influent and effluent were selected to allow comparison of PhAC
concentrations before and after wastewater treatment. Rio Grande 1 sampling site was
selected to measure the occurrence of PhACs in the river upstream from the SWRP
effluent location. Rio Grande 1 is also near the proposed intake for the City of
Albuquerque Drinking Water Program (City of Albuquerque, 2003). The Rio Grande 2
sampling site was located downstream of SWRP effluent, and intended to be just far
enough below the discharge point to allow mixing of effluent with river water. The
comparison of Rio Grande 1 with Rio Grande 2 allows comparison of Rio Grande waters
before and after the addition of SWRP discharge. Rio Grande 3 was selected to offer
insight into the fate and persistence of PhACs in the Rio Grande.

2.3 Sampling Protocol
This study was conducted in accordance with the EPA-approved Quality Assurance
Project Plan (QAPP) for the NMED (New Mexico Environment Department, 2003).
Samples were collected between March 30, 2003 and May 7, 2003.

The sampling at sites 1-5 was performed using an ISCO GLS automated composite
sampler (Table 3). At these five sites, forty-eight 125 ml samples were collected in 5minute increments between 6 a.m. and 10 a.m., resulting in 6-liter composite samples.
Each collection was compiled in a 2.5 gallon glass bottle inside the ISCO sampler,
surrounded by ice and protected from sunlight. After collection, the composite samples
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were transferred to six 1-liter brown glass bottles, stored on ice, and delivered to SLD
within 24 hours.

For sampling sites 6 and 7, samples were collected by City of Albuquerque as part of the
official sampling events at SWRP (Table 3). Each of these approximate 6-liter composite
samples was comprised of approximate 1-liter samples that were collected every four
hours and compiled over two consecutive 24-hour periods. The City of Albuquerque lab
used three of six liters from each 24-hour sample and donated the remaining three liters
for use in this study. Since approximately six liters were required for this study, three
liters from the first 24 hour sample remained refrigerated at 4º C and out of sunlight at the
City of Albuquerque lab while awaiting the second 24-hour sample. The two 3-liter 24hour samples were composited and mixed in a large glass jar and then redistributed into
six 1-liter brown glass bottles, stored on ice, and delivered to SLD within 24 hours.
Although the collection times were dictated by the City of Albuquerque’s established
protocol, the 48–hour composite sample was ideal as it allowed for capture of a
representative sample that accounted for high and low flow periods within a day
(Kearsey, 2003, personal communication; unreferenced).

For sampling sites 8-10, six 1-liter grab samples were collected in brown glass bottles,
composited and mixed in a large glass jar, and then redistributed into six 1-liter brown
glass bottles (Table 3). Samples were collected across the channel and at variable depth
profiles (shallow to deep) at each river sampling site based on accepted USGS technique
(Kolpin et al., 2002). Samples were stored on ice and delivered to SLD within 24 hours.
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Attempts were made by SLD to extract all samples within 48 hours of collection;
however, the Rio Grande samples remained refrigerated at 4º C for four days before
being extracted.

Equipment and field blanks were collected and analyzed based on the NMED QAPP
(New Mexico Environment Department, 2003). The equipment blank involved sampling
of three liters of de-ionized water from a glass jar using the ISCO composite sampler.
The collected sample was then redistributed into three 1-liter brown glass bottles, and
immediately stored at 4º C at SLD. A field blank was collected at the VA hospital site by
placing three 1-liter brown glass bottles of de-ionized water (open to the environment)
next to the ISCO sampler for the duration of the sampling event. The three 1-liter
equipment blank samples were stored on ice and delivered to SLD along with the VA
sample. Sample temperature, pH, specific/electrical conductance, and total dissolved
solids concentrations were collected and are presented along with other sample site
collection details in Appendix B. Rio Grande flow rates were obtained from USGS gage
data (USGS, 2003).

2.4 Analytical Methods
In the process of developing the analytical techniques used in this study, SLD
encountered difficulties associated with analyses of very low concentrations of PhACs in
raw wastewater. Several PhACs originally intended for analysis had to be eliminated due
to difficulties associated with extraction and recovery. For instance, erythromycin
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appeared to dehydrate resulting in poor recovery due to multiple product formation
during MS/MS analyses. Tetracyclines tended to complex with metals making them
difficult to extract with Solid Phase Extraction (SPE). Additionally, many of the PhACs
were very sensitive to pH such that two different pH extractions had to be conducted for
optimum recovery to occur. Although clogging of SPE cartridges was anticipated for the
raw sewage samples, no centrifuging was necessary to achieve optimal extraction.
Similar difficulties arose with analyses of non-antibiotic PhACs; however, these issues
were resolved with prior NMED/SLD studies (Chapman, 2003, personal communication,
unreferenced).

Antibiotic samples were extracted using Solid Phase Extraction (SPE) at two pHs. The
first set was brought to a pH of 9.5 using 2M ammonium hydroxide, while a pH of 3.5
was achieved for the second set using formic acid. All samples were extracted at both
pHs to determine optimum extraction. Extracted samples were concentrated to 1ml. and
analyzed by high performance liquid chromatography (HPLC) and tandem mass
spectrometry (MS/MS) using Agilent 1100 liquid chromatograph interfaced to Applied
Biosystems API 4000 mass spectrometer. (Chapman and Mawhinney, 2003, manuscript
in preparation; unreferenced).

The non-antibiotic PhACs were analyzed using techniques developed in previous
NMED/SLD studies (McQuillan, 2001). Samples were extracted with a dichloromethane
liquid-liquid extraction (LLE) and then concentrated down to 1 ml. Sampling was
performed using a Varian 8200 automatic sampler. Samples were analyzed by gas
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chromatography (GC) and MS/MS using a Varian 3800 gas chromatograph coupled to
Saturn 2000 mass spectrometer (Chapman and Mawhinney, 2003, manuscript in
preparation; unreferenced).

Each sample batch was analyzed along with lab reagent blanks, lab fortified blanks, and
lab fortified matrices as controls. All positive results were quantified using freshly
prepared chemical standards.

The sample detection limit (SDL) for all antibiotics and non-antibiotic PhACs was10
ng/l. Recoveries ranged from 80 to120 percent. Conjugate forms of the PhACs, such as
glucuronides and sulfates, were treated as transformation products and are not accounted
for in the concentrations detected. Since some conjugates can be converted back into the
original PhAC form before or during wastewater treatment processes, this may result in
an underestimation of the concentration of PhACs present in samples (Huang et al.,
2001). Chemical characteristics and pharmacokinetics for several of the detected
antibiotics are presented in Appendix C.
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3.0 RESULTS AND DISCUSSION

First, it is important to note that this study does not quantify the total load of PhACs
contributed from any sample source because flow volume during sample collection was
not known. Instead, what can be determined is a concentration of parent compound
present in the sample at the time of collection. Secondly, the study design did not allow
PhACs to be tracked temporally (i.e. from hospital to SWRP to river). Consequently,
while results do reflect occurrence concentrations at time of collection, it is not feasible
to definitively claim that differences in concentrations detected from source to river
actually reflect removal of the PhACs within the system. Finally, only the parent
compounds of the 39 PhACs were investigated. Conjugates and metabolites of the parent
compounds, while sometimes pharmaceutically active, were not included in analytical
testing. Consequently, by tracking only parent compounds, these results likely
underestimated the concentration of PhACs present in the samples.

Ten sampling sites were investigated for the presence of thirty-nine PhACs comprised of
29 non-antibiotic PhACs and 10 antibiotics. Analytical results of all PhACs detected are
presented in Table 4. Of the 29 non-antibiotic PhACs tested, only caffeine was found and
only at the Presbyterian Hospital site (3000 ng/l). However, a number of antibiotics were
detected, with six of the ten antibiotics found (Figure 1). Each of the six antibiotics
detected were found at two or more sites (Figure 1). Additionally, of the ten sampling
sites investigated, eight sites had at least one of the 39 PhACs present while five sites had
three or more PhACs present (Figure 2).
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Table 4: PhACs detected at sampling sites (ng/l). Blank boxes indicate no detection.
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Figure 1: Number of sites where a particular antibiotic was detected. This graph also shows that six of the
ten antibiotics were detected while four were absent from all sampling sites.
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Figure 2: Number of PhACs detected at each sampling site. As expected, hospitals had the most PhACs
detected and the river the least. Also, eight of the ten sampling sites had at least one PhAC present and two
sites had none.

3.1 Fate and Persistence of PhACs in the Environment
Once a PhAC enters wastewater or natural waters, several processes affect its fate and
transport in the environment. These processes include 1) sorption, 2) biotic
transformation, and 3) abiotic transformation (Huang et al., 2001). The fate and
persistence of PhACs in the environment is affected by their sensitivity to these
processes. Research based on the chemical properties and structures of PhACs has
improved our ability to predict the sensitivity of PhACs to these processes and hence,
their expected fate and persistence (Huang et al., 2001). Furthermore, it is now
understood that classes of drugs that have similar chemical properties and characteristics
tend to behave similarly in the environment. See Appendix D for details regarding
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specific chemical properties and pharmacokinetics of the three antibiotics detected in
SWRP influent and effluent.

The likelihood of detecting specific drugs can be predicted by combining knowledge
regarding the concentrations and fate of PhACs within the same class (Huang et al.,
2001). Regarding antibiotics, their persistence and transport in the environment has been
predicted by Huang et al. (2001), as follows: sulfonamides and fluoroquinolones are the
most persistent followed by macrolides; tetracyclines can persist for relatively long
periods if sunlight is not present, but tend to be less mobile, and aminoglycosides and β lactam antibiotics show the least persistence. However, it is important to realize that it is
not essential for a PhAC to be persistent in the environment in order for it to have
significant impact. Instead, the PhAC could be present at concentrations of concern
simply by continual infusion into the environment (Daughton and Ternes, 1999).

With regard to antibiotics in wastewater and surface water, previous studies have shown
tendencies for some classes of antibiotics to be detected while others are not. In
wastewater and surface waters, tetracycline and β-lactam antibiotics have been found
rarely, trimethoprim occasionally, and sulfonamide, fluoroquinolone, and macrolide
antibiotics frequently (Huang et. al, 2001). Research by Huang et al. (2001), identified
antibiotics that were most likely to be found in wastewater sources by combining
information concerning environmental fate with predicted concentration levels of
different antibiotics. From their respective classes, sulfamethoxazole, ciprofloxacin, and
azithromycin were predicted to be the leading wastewater effluent antibiotics (Huang et
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al., 2001). This predictability of detection is largely related to stability of these
compounds in the environment. As such, the sulfonamides and fluoroquinolones,
followed by macrolides, are the least susceptible to transformation and more likely to
persist and transport in aqueous environments (Huang et al., 2001). Additionally, the
fluoroquinolones and tetracyclines degrade very slowly as long as sunlight is limited
(Huang et al., 2001). Tetracyclines adsorb to soils and sediments most readily,
fluoroquinolones and macrolides moderately, sulfonamides moderately to weakly, and
aminoglycosides and β-lactams weakly (Huang et al., 2001). In addition to predictions
regarding fate and persistence, Huang et al. (2001) also estimated antibiotic
concentrations in untreated wastewater to range from 3.9 ng/l to approximately 27,000
ng/l. Interestingly, these predictions regarding fate, persistence, and concentrations are
similar to the results obtained in this project (Table 4). See Appendix D for additional
fate, transport and persistence characteristics for common antibiotic classes.

3.2 Detection of Antibiotics vs. Other PhACs
While antibiotics were detected in all hospital samples, it is surprising and not well
understood why none of the non-antibiotic PhACs were detected, or why caffeine was
detected at only one site. Although beyond the scope of this study, the absence of these
non-antibiotic PhACs from all samples may be due to 1) lower prescribed use, 2)
differences in excretion and metabolism of parent compound, 3) lower persistence and
transport due to differences in chemical properties and structures of non-antibiotic drugs,
and/or 4) analytical error/inaccuracies associated with the analytical techniques used for
the non-antibiotic drugs compared with that used for antibiotics.
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3.3 Occurrence of PhACs in Hospital and Residential Effluent
The first objective of this study was to investigate the occurrence of PhACs in hospital
and residential wastewater and, when present, to document their concentrations. In this
regard, data reveals that all three hospitals are in fact significant source contributors of
several antibiotics but not of non-antibiotic PhACs (Figure 3). In addition, one hospital
was also a source contributor of the PhAC, caffeine. Six of the ten antibiotics investigated
were detected at the hospital sites (Figure 3). As predicted by Huang et al., 2001, the drug
classes of fluoroquinolones and sulfonamides are well represented. This is reflected by
the presence of ofloxacin and sulfamethoxazole at all three hospital sites, and
ciprofloxacin at two hospital sites. Ofloxacin was found at particularly high levels in all
three hospital’s wastewaters.
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Figure 3: PhACs detected in effluent from hospital and residential sites
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UNM Dorm

Vista del Rio

In contrast to hospital effluents, residential point source contributions were minimal as
indicated by the absence of PhACs at the UNM Alvarado Dormitory, and the detection of
only one antibiotic, ofloxacin, at Vista del Rio Assisted Living (Figure 2). Also, in
comparison to the concentrations found at hospital sites, the concentration contributed
from Vista del Rio is nominal.

3.4 Genotoxicity in Hospital Effluent
Genotoxicity refers to the amount of damage a toxin can do to DNA molecules.
Genotoxic substances are also often mutagens and carcinogens (Hartmann et al., 1998).
Fluoroquinolone antibiotics, particularly ciprofloxacin, have been shown to display
genotoxic effects in hospital effluent where concentrations were in the 3000ng/l to 87,000
ng/l range (Hartmann et al., 1998). While ciprofloxacin was only found at a maximum
concentration of 2000 ng/l in this study, temporal and spatial variability in effluent
concentrations are likely to exist and could result in concentrations within the genotoxic
range at times. Additionally, ofloxacin, which is also a fluoroquinolone but was not
specifically addressed in the Hartmann et al. study, was found at very high concentrations
in all three hospital samples and is therefore also of concern for its potential contribution
to genotoxic effects.

At concentrations found in hospital effluent, genotoxic effects from ciprofloxacin most
significantly impair prokaryotic rather than eukaryotic organisms and do not appear to
pose an acute human genotoxic risk (Hartmann et al., 1998). Still, prokaryotic organisms
can be found in the activated sludge of sewage treatment plants where they could come
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into contact with significant concentrations of fluoroquinolone antibiotics (Hartmann et
al., 1998). While not well understood, there is concern that this type of exposure could
result in the disruption of microbial ecology or perhaps facilitate the proliferation of
antibiotic-resistant organisms.

3.5 Differences in Occurrence and Concentration of PhACs from Source to
SWRP Influent
While hospital effluent samples contained six different antibiotics and caffeine, the
wastewater sample collected at the SWRP influent site contained only three antibiotics
(Figure 4). Four antibiotics and caffeine dropped below detection levels between the
primary source and SWRP. This difference in concentrations of antibiotics between the
source samples 1-5 (Table 3) and the SWRP influent can likely be attributed to: 1)
dilution by other wastewater sources that do not contain PhACs, and /or 2) processes
affecting the fate and transport of the PhAC such as sorption, biotic, and abiotic
transformations (Huang et al., 2001). However, since the study design did not allow for
hospital and residential effluent to be tracked temporally from source to SWRP influent,
it is possible that the sample of influent collected at SWRP did not contain any of the
originally sampled hospital or residential effluent but instead contained effluent that
never had detectable concentrations of the PhAC. While it is likely the case that the drop
in concentrations of PhACs in wastewater is primarily due to dilution and/or one of the
processes affecting fate and transport, it is important to understand that temporal
variations in concentration of PhACs in hospital or residential discharges may also
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contribute. Determination of exact processes affecting concentrations and fate of PhACs
from source to river is an important area for further research.
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Figure 4: Differences in concentrations of PhACs between their sources and the SWRP influent. The
reduction in concentrations of PhACs between their various point sources and the SWRP influent ranges
from 2-81% for sulfamethoxazole, 80-88% for trimethoprim, and 64-99% for ofloxacin.

3.6 Concentrations of PhACs Before and After Wastewater Treatment
The second objective of this study was to assess removal of PhACsby the SWRP. Three
antibiotics (sulfamethoxazole, trimethoprim, and ofloxacin) were present both in the
SWRP influent and effluent samples. Interestingly, these PhACs appear to have
experienced between 20 and 77 percent removal (Figure 5). While the experimental
design of this study makes it imprudent to definitively claim that SWRP removed these
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PhACs, the fact that SWRP influent and effluent samples were 48-hour composites does
lend some confidence to the results. Consequently, it is likely that one of the SWRP
700
SWRP Influent
SWRP Effluent

600

ng/l (ppt)

500
400

20%
reduction

300

69%
reduction

200

77%
reduction

100
0
Sulfamethoxazole

Trimethoprim

Ofloxacin

Antibiotics
Figure 5: Removal efficiency of SWRP for the three antibiotics detected in the SWRP influent

treatment processes (activated sludge or chlorination) was responsible for the observed
reductions. It is also notable that the removal efficiency by SWRP varies for the three
antibiotics. This variability is likely due to differences in chemical properties and
structure of the PhACs that make them more or less sensitive to SWRP treatment
processes and consequently result in different removal efficiencies. Interestingly, all three
PhACs present in SWRP samples were from different drug classes and therefore, as
predicted by Huang et al. (2001), were expected to behave differently, and in fact, did.
Sulfamethoxazole, (a sulfonamide) demonstrated poor removal, whereas, trimethoprim
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(classified as ‘other’) and ofloxacin (a fluoroquinolone) were both more efficiently
removed, though to differing degrees (Huang et al., 2001). Again, the exact processes
(sorption, biotic or abiotic transformation) responsible for the removal are not known and
are beyond the scope of this study. However, it would be interesting to collect samples
between different treatment phases within SWRP to determine which phase and
processes are responsible for the removal or transformation of each PhAC.

Following treatment at the SWRP, three antibiotics were detected in the SWRP effluent.
This effluent is thus continually infusing antibiotics into the Rio Grande, though at
relatively low concentrations. The effects of this discharge are not known. In fact, little is
known at all about the acute or long-term effects to aquatic species or, more generally,
about safe allowable limits of PhACs in the environment. Consequently, the inability of
SWRP to fully remove PhACs is disconcerting. Advanced wastewater treatment
techniques such as reverse osmosis, activated carbon, and ozonation have been shown to
significantly reduce or eliminate antibiotics – including sulfamethoxazole – from
wastewater effluents; however, most wastewater treatment facilities do not employ these
techniques (Huang et al., 2001; Sedlak and Pinkston, 2001). Furthermore, even if these
advanced techniques were widely employed, these processes have not been shown to
fully remove all PhACs and, consequently, issues surrounding potential long term effects
at low concentrations of PhACs could continue to be a concern (Daughton and Ternes,
1999; Sedlak and Pinkston, 2001).
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3.7 Occurrence and Fate of PhACs in the Rio Grande
The final objective of this study was to investigate the occurrence and fate of PhACs in
the Rio Grande by collecting samples both upstream and downstream of SWRP. With
regard to occurrence, no PhACs were detected at Rio Grande 1, upstream of SWRP, and
only one antibiotic, sulfamethoxazole, was detected at the two sampling sites below
SWRP (Figure 6). The lack of detection of PhACs at Rio Grande 1 is consistent with two
prior NMED studies in which PhACs were undetected in samples from this location
(McQuillan, 2001, 2002). This is good news since this is near the planned diversion site
for the City of Albuquerque’s Drinking Water Program.
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Figure 6: Concentration of antibiotics at SWRP and in the Rio Grande
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Ofloxacin

Rio
Grande 3

Although three PhACs were detected in the SWRP effluent, the trimethoprim and
ofloxacin were present at very low concentrations. It is reasonable to assume that dilution
by the river caused these two antibiotics to drop below detection limits in the Rio Grande
since the Rio Grande flow rate was 5.5 times that of the SWRP effluent (See Appendix
A). However, it is possible that photolysis or some other transformative process might
also have played a role. Fluoroquinolones are especially susceptible to photodegradation
(Huang et al., 2001) for which the wide and shallow river morphology of the Rio Grande
offers ample opportunity. Consequently, photodegradation must be considered a possible
explanation for the absence of ofloxacin from the Rio Grande samples.

Similarly, the fact that the sulfamethoxazole concentration remains relatively stable in the
SWRP effluent and in Rio Grande samples 2 and 3, seems to support the predictions
made by Huang et al., (2001), that sulfamethoxazole is not particularly sensitive to
photolysis or other transformation processes and tends to persist and transport readily in
the environment. Alternatively, it is unclear why the concentrations of sulfamethoxazole
in the SWRP effluent and Rio Grande samples 2 and 3 remain virtually unchanged when
dilution alone should have resulted in a 5.5 fold reduction (Appendix A). Possible
explanations for this result might include: 1) the SWRP effluent contained conjugates or
metabolites of sulfamethoxazole that were not accounted for in analysis and were not in
pharmaceutically-active forms in the SWRP effluent but were later converted back to the
detectable parent form of the drug after reaching the river, or 2) temporal variations in
sulfamethoxazole concentrations exist in the SWRP effluent from day to day.
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Since study design did not temporally track samples from the SWRP into the Rio Grande,
temporal variations could potentially explain this result. In fact, the Rio Grande samples
were collected about a week before the SWRP effluent samples. Consequently, if the
SWRP effluent entering the Rio Grande on the day of collection of the Rio Grande 2 and
3 samples had concentrations of sulfamethoxazole 5.5 times greater than those detected
in the SWRP effluent in this study, the concentration of sulfamethoxazole found in this
study in Rio Grande 2 and 3 samples would be consistent with dilution effects.
However, since temporal fluctuations of this magnitude are unlikely, it is possible that
some combination of factors was responsible for the results obtained.
Maintaining adequate flow in the Rio Grande is important for the preservation of water
quality because it allows for the dilution of contaminant loads entering the river. With the
City of Albuquerque Drinking Water Program, additional water will be diverted from the
Rio Grande. The City of Albuquerque will be diverting 94,000 af/y but predicts the
effective loss of flow through Albuquerque to be minimal, at 34,000 af/y. At present, on
the collection date of 3/31/03, the SWRP effluent was 15.4% of the Rio Grande flow.
This would increase to 16.9% if 34,000 af/y were effectively lost as predicted (Appendix
A). While not a significant change, this could potentially raise PhAC concentrations as
well as other chemical pollutant concentrations to levels of concern.

3.8 Comparisons with Prior Studies
The finding of sulfamethoxazole in the Rio Grande is consistent with results obtained by
the USGS in their surveillance of US streams in 1999 and 2000 where sulfamethoxazole
and trimethoprim were both detected in 12.5 percent of 104 streams with a median
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concentration of 150 ng/l (Kolpin et al., 2002). It is curious, however, that trimethoprim
was not detected in the Rio Grande since these two drugs frequently appeared to be
detected together and in similar concentrations by the USGS (Kolpin et al., 2002) (Table
5). Perhaps the answer lies in the differences of removal by SWRP where trimethoprim is
reduced by approximately 69 percent and sulfamethoxazole by only 20 percent (Figure
5). This may indicate that treatment processes within SWRP are affecting the
trimethoprim more readily than the sulfamethoxazole. Table 5 is included to allow for
further comparison of results from USGS, NMED, and this study (Kolpin et al., 2002).

Similarly, it is also interesting that in previous NMED studies involving Rio Grande
samples, other PhACs, such as estrone, amitriptyline, and caffeine were detected. In light
of these findings, it is somewhat surprising that none of these PhACs were detected in
this study, particularly since the Rio Grande sample sites in this study focused on
Albuquerque, the most populated region in New Mexico. Analyses were performed by
SLD for both this study and the prior NMED studies when these other PhACs were
detected (McQuillan, 2000, 2001). However, new instrumentation not previously used by
SLD was utilized for this study and therefore, might explain the different findings.

However, a recent study conducted by the U. S. Fish and Wildlife Service and SLD
(using the older instrumentation) investigated the same 29 non-antibioitic PhACs tested
for in this study, and detected only 17β-estradiol at the analytical detection limit of 10
communication, unreferenced). None of the 29 non-antibiotic PhACs were detected in
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Table 5: Comparison of PhACs detected in three different studies:
1) U.S. Streams by the USGS (Kolpin et al., 2002), 2) the Rio Grande in prior NMED
studies (McQuillan, 2001), 3) the Rio Grande in this study.
Concentrations
USGS*
USGS median found in Prior Concentration
frequency of concentration NMED studies detected in this
PhAC
detection (%) (ng/l)
(ng/l)
study (ng/l)
sulfamethoxazole
12.5
150
0
300
trimethoprim
12.5
150
0
0
norfloxacin
0.9
120
0
0
lincomycin
19.2
60
0
0
oxytetracycline
1.2
340
0
Not tested
sulfamethazine
4.8
20
0
0
sulfamethizole
1
130
0
0
tylosin
13.5
40
0
0
fluoxetine
1.2
120
0
0
caffeine
61.9
81
200 and 1500
0
cholesterol
84.3
830
0
0
equiline
1.4
147
0
0
17α-ethynl
estradiol
15.7
73
0
0
17β-Estradiol
10.6
160
0
0
mestranol
10
74
0
0
estrone
7.1
27
140
0
amitriptyline
Not tested
Not tested
30
0
*The USGS study detected additional compounds but only those also tested for in the other studies are
included here for comparison

Albuquerque reaches of the Rio Grande despite use of the older analytical
instrumentation. This indicates that the difference in instrumentation is unlikely to be
responsible for the differences in results.

A second possible reason that NMED may have detected PhACs that were not detected
by this study or the U. S. Fish and Wildlife Service study, might include differences in
dilution of wastewater effluents due to differences in Rio Grande flow rates at time of
collection. However, it is unlikely that flow was less during the NMED study than during
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this study as collections for this study were performed during a very low flow period (446
cfs).

Alternatively, it is possible that differences are due to spatial variability between the Rio
Grande sample locations selected in each study despite relatively close proximity.
Specifically, in the NMED study, estrone and caffeine were found “in the South Valley”.
However, the exact location as it compares to the Rio Grande sample locations from this
study is not known but could be miles away.

A final possible explanation might be differences in photodegradation effects due to
differences in sunlight during or preceding collection of Rio Grande samples, although, it
is known that both the NMED and this study collected Rio Grande samples on sunny
days. The differences found between all of these studies and the proposed explanations
clearly reflect the inherent difficulties in studying PhACs and offer a glimpse of the
myriad variables involved in fully understanding this issue.
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4.0 CONCLUSION

This study establishes a preliminary inventory of PhACs in effluent from hospital and
residential sources, raw influent and treated effluent at the City of Albuquerque
municipal wastewater treatment plant, and the Rio Grande in Albuquerque, NM. As
anticipated, hospitals were found to be a significant source of antibiotics with
concentrations ranging from 300 ng/l to 35,000 ng/l. On the other hand, sampling of
residential wastewater resulted in detection of only one antibiotic. However, it is
important to remember that while concentrations from individual residential sources may
be low or below detection levels, they can be numerous and, when combined, may
contribute a relatively significant load of PhACs to wastewater.

While antibiotics were detected in all hospital samples, it is surprising and not well
understood why none of the non-antibiotic PhACs were detected, or why caffeine was
only detected at one site. One explanation might be due to differences in chemical
properties/structures that limit the persistence and transport of the non-antibiotic PhACs
more readily than the antibiotics. It is also possible that interferences associated with the
high concentrations of solids and organics in raw wastewater limited the ability to detect
these compounds at trace levels.

Three antibiotics (sulfamethoxazole, trimethoprim, and ofloxacin) were detected in the
SWRP influent and effluent at levels ranging from 470 ng/l in the influent to 110 ng/l in
the effluent. Specifically, concentrations of these PhACs in the effluent sample are
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reduced between 20 and 77 percent by the SWRP treatment processes. This difference in
response to the treatment processes at SWRP is believed to be attributable to differences
in the chemical properties and structures affecting their fate and persistence in the
treatment environment.

With regard to occurrence of PhACs in the Rio Grande, none were detected at the
sampling site upstream of the SWRP, and only one antibiotic, sulfamethoxazole, was
detected at the two sampling sites below the SWRP (300 ng/l). The trimethoprim and
ofloxacin, present at relatively low concentrations in the SWRP effluent, but absent in the
river, are assumed to have dropped below detection limits due to dilution by the river.
However, the possibility that photolysis or some other transformative process might also
have played a role cannot be ruled out. With respect to the sulfamethoxazole, it appears
to be resistant to transformation and persists in the river over a distance of approximately
five miles with no change in concentration.

Overall, the results of this study are not alarming. Despite prior NMED detection in the
Rio Grande, no estrogenic hormones were found. This data may ease the concern
regarding possible environmental problems due to the presence of estrogenic hormones.
In addition, although antibiotic concentrations in hospital effluent were relatively high,
detection and concentration in the Rio Grande was minimal with only sulfamethoxazole
being detected.
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Still, issues of concern do arise. With relatively high levels of two fluoroquinolone
antibiotics detected in hospital effluent and one fluoroquinolone present in SWRP
influent and effluent, the issue of genotoxicity and its resultant impairment of prokaryotic
organisms is of concern for its potential to disrupt microbial ecology (Hartmann et al.,
1998). Also, with multiple antibiotics detected in all three hospital effluents, the research
by Guardabassi et al, (1998) is of particular interest. This study lends credence to the
concern that bacteria may develop antibiotic resistance through exposure to antibiotics in
hospital or pharmaceutical plant wastewater effluents. Presently, little is known regarding
environmentally safe levels for antibiotics in wastewater or surface waters. Clearly more
research is needed to quantify the risk such that appropriate action can be taken to
mitigate harmful effects or alternately, redirect efforts and limited resources. However,
complicating factors such as the temporal and spatial variability in PhAC detections make
it difficult to compare studies, assess risk, or institute policy.

While the relatively low concentrations of sulfamethoxazole detected in the Rio Grande
are not known to cause any human or ecological health risks, it is still wise to employ the
precautionary principle and focus on reducing or eliminating the occurrence of PhACs
whenever possible. To this end, the quantification of PhAC contributions from hospitals
provides valuable information that should be used to educate and motivate the medical
community to improve clinical practice standards regarding the dispensing and disposal
of medications as discussed in the USGS concept of “Green Pharmacy” (Daughton,
2003). In addition to reducing the load of PhACs entering wastewater, improvement of
wastewater treatment technology and wider use of existing technology (reverse osmosis,
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activated carbon, and ozonation) is warranted. Ultimately, it is my hope that the results of
this study can be used as a foundation for future management decisions affecting water
quality and its consequences for aquatic and human species.
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5.0 SUGGESTIONS FOR FUTURE WORK
In the past decade, concern regarding chemical pollution has expanded beyond the
traditional priority pollutants to include micro-contaminants such as PhACs. Research on
this topic has been increasing worldwide, particularly in Europe and in the United States,
where several instrumental studies have been conducted by U.S. governmental agencies.
Although significant advances have been made, many questions remain. More research is
needed in all areas; but, areas of particular importance might include identification of: 1)
source contributions, 2) fate and transport characteristics, 3) wastewater treatment
removal efficiencies, 4) effects on aquatic and other species, and 5) optimization of
analytical techniques. While future research opportunities are seemingly limitless, several
topics have been identified during the course of this project. Furthermore, many of the
suggestions stated here would specifically benefit New Mexico and could potentially be
conducted on relatively limited budgets.

Generally speaking, investigation into issues of temporal variability is important.
Clarification or illumination of temporal trends might explain some of the observed
differences between studies and help to direct future sampling protocols. For instance,
results might help illuminate the relative importance of composite vs. grab sampling
techniques or help determine appropriate composite collection schedules. Investigation of
temporal variability could be addressed for source contributions, wastewaters, surface
waters or any sample of concern. Specifically, this might include sampling hourly over a
24-hour period to determine how hospital effluent, wastewater, or surface water
concentrations vary. Temporal sampling could also be done daily at the same time of day
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to determine changes not associated with diurnal patterns but rather fluctuations from day
to day. Seasonal collections might also be of interest due to potential seasonal variability
in PhAC usage.

Another general consideration in study design might involve evaluation of analytical
techniques. Samples could be sent to two or more labs to evaluate the reliability and
validity of results. For instance, results could be compared between labs analyzing the
same sample with different techniques or between labs utilizing different techniques to
analyze the same sample.

With regard to source contributions, it is worth considering determination of the total
load of PhACs contributed by a given source. To do this, it is necessary to know the flow
rate during sample collection. Total load is important when trying to perform a mass
balance approach to tracking PhACs throughout their course to determine fate and
transport in the environment. While this is an increasingly popular approach, it does add
another level of complexity to the study design. Additionally, it is not necessarily an
essential component for inventory studies since the concentration of PhAC is generally
the issue of concern in regard to effects on aquatic species.

In light of the relatively high concentrations of antibiotics found in hospital effluents in
this study, contacts have been made at University Hospital to educate and motivate the
medical community to improve clinical practice standards regarding the dispensing and
disposal of medications as discussed in the USGS concept of “Green Pharmacy”
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(Daughton, 2003). As an employee of University hospital it is the author’s intention to
encourage and participate in the implementation of this process. Additionally, however,
further research is needed to assess the environmental risks associated with these
genotoxic substances. In general, the potential for antibiotic resistance to develop in
organisms exposed to very low concentrations of antibiotics in the aquatic environment
needs to be addressed. Although this pathway for the development of antibiotic resistance
is widely discussed in the literature as an emerging threat, little documentation is
available to validate the concern (Guardabassi et al., 1998). Further research is urgently
needed to quantify the risk such that appropriate action can be taken to mitigate harmful
effects or alternately, redirect efforts and limited resources.

Another major topic for further investigation involves wastewater treatment techniques
and their PhAC removal efficiencies. There are numerous studies that have documented
the removal of PhACs by various wastewater treatment facilities. However, more clarity
is needed in determining the exact processes responsible for the removal. To assess this,
samples could be collected at the SWRP influent, between each distinct treatment
process, and at the effluent. Another interesting project might be to compare removal
efficiencies at SWRP with those at the Santa Fe wastewater treatment plant since these
facilities utilize different techniques (UV radiation vs. chlorination specifically). Also,
with the planned implementation of the Albuquerque Drinking Water Program and its
associated additional Rio Grande diversion, the SWRP will likely become a slightly
greater percentage of the Rio Grande flow, consequently minimizing dilution by the river.
If the impact on flow is significant, it might be interesting to resample the Rio Grande
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sites investigated in this study to see if additional PhACs are detected or if concentrations
are elevated.

Since some PhACs tend to adsorb to soils and clay, it would be interesting to investigate
the presence of PhACs in riverbed sediments in the Rio Grande, downstream of the
SWRP. Similarly, it might be interesting to sample soils near landfills, particularly those
that receive wastewater treatment sludge. Soils from city parks or golf courses that are
irrigated with surface water might also be of interest. Furthermore, groundwater
associated with each of these soil samples could be sampled to assess for leaching of
PhACs into groundwater.

Recent literature reflects a trend away from simply quantifying aqueous concentrations
and instead, is moving toward the tracking of PhACs utilizing a mass balance approach
that addresses the ultimate fate of the PhAC. To address these issues of fate, it is
important to determine the transformation and degradation processes involved. For
instance, some PhACs tend to adsorb to sludge during the treatment process, others may
biodegrade or form transformation products due to alterations in their chemical
structures. A clearer understanding of the fate of PhACs in wastewater treatment plants
could be achieved by analyzing the mass of PhACs in the aqueous phase and in
wastewater sludge (to account for sorption processes). Additionally, attempts could be
made to track other transformation/degradation products when the chemical structures of
the products are known.
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In addition to these specific areas of focus, there are many other research opportunities
that might best be addressed in a laboratory. For instance, the effects of photodegradation
could be evaluated for different PhACs and drug classes to help determine sensitivity to
this degradation process. Another project would be to investigate tendencies of PhACs to
adsorb to sludge, soils, clay, or minerals. This project would help to advance our
understanding of the fate and persistence of PhACs in the environment

Research pertaining to effects on aquatic species is another area where laboratory
research is indicated and more research is essential. This is particularly true in regard to
estrogenic compounds and as noted previously, antibiotics. Research investigating longterm low dose exposure to PhACs is an area of particular concern. Similarly, there is
much interest in the potential risk to aquatic organisms associated with concurrent
exposure to combinations of PhACs, particularly when the drugs in combination are from
the same drug class or tend to act similarly on the target organism.

In conclusion, this issue of PhACs in the environment is an area of much concern for a
wide variety of environmental disciplines. Input from diverse fields of study is essential
to gain a clear and thorough understanding of this complex topic. While a few
suggestions have been made here, there are myriad other opportunities available for
further research in this fast-growing and interesting area of study.

“Not everything that can be counted counts, and not everything that counts can be
counted”
- Albert Einstein
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GLOSSARY OF TERMS
Abiotic transformation: A non-biologically induced change in the PhAC. Hydrolysis
and photolysis are common degradation pathways for PhACs whereas little is know about
other types of abiotic transformation such as oxidation and reduction processes as they
apply to PhACs in the environment (Huang et al., 2001)
Antibiotic: A drug class. Antibiotics are a special class of drug. Antibiotics are drugs that
are used to fight infections. In this study they were categorized separately from the other
PhAC because they required application of a different analytical detection technique and
because as a class they are of particular concern in the environment due to their potential
to facilitate the proliferation of antibiotic-resistant organisms.
Antibiotic resistance: When bacteria develop this, antibiotics are no longer effective at
stopping their growth and infections can flourish. Illnesses caused by such bacteria are
consequently difficult to control and can spread rapidly. Strains of bacteria that display
antibiotic resistance seem to be on the rise.
Anti-convulsants: A drug class; a drug used to treat or control convulsions such as in
epilepsy.
Anti-depressants: A drug class; a drug used to treat depression (these often have
undesirable side effects
Anti-inflammatories: A drug class; a drug used to treat or control inflammation
Analgesic: A drug class; a drug used to decrease pain.
Biochemical processes: Reactions of chemical compounds such as sorption, biotic
transformation, and abiotic transformation (Huang et al., 2001)
Biotic transformation: Changes in PhACs due to biological processes; biodegradation
Class: See Drug class
Drug: The active ingredient in a PhAC; a substance other than food intended to affect the
structure or function of the body (http://www.m-w.com/cgi-bin/dictionary); In this study
drug and PhAC are interchangeable
Drug class: A categorization or grouping of drugs based on commonalities regarding
their effects on target organs or organisms. Drugs in the same class tend to behave
similarly and often have similar chemical and physical properties.
Effluent: Flowing out
Fate: What happens to a PhAC throughout its existence in the environment; i.e. is it in
the aqueous phase, adsorbed to a solid, or transformed or degraded into a non-PhAC.
Fluoroquinolone: A type or sub-classification of antibiotics
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Genotoxicity: The amount of damage a genotoxic substance can cause to a DNA
molecule. Genotoxicity also relates to mutagenicity and carcinogenicity.
Genotoxic effects: DNA damage
Hormones: A drug class; a chemical substances created by the body or synthetically
produced that control numerous body functions; examples include birth control pills and
hormones used for hormone replacement therapy in menopausal women.
Hospital source: A location that contributes PhACs from a hospital to the wastewater
system. In this study there are three sampling sites that are hospital sources: Presbyterian,
UNM, and the VA Hospitals.
Influent: Flowing in
Lab reagent blank: Whatever solvent is used for analysis. In this study it is de-ionized
water for the antibiotics and dichloromethane for the non-antibiotic PhACs.
Lab fortified blank: The analytical solvent (de-ionized water or dichloromethane)
spiked with standards of all the PhACs to be investigated.
Lab fortified matrixes: An actual field sample spiked with standards of all the PhACs to
be investigated.
Macrolide: A type or sub-classification of antibiotics
Microgram/liter (µg/l): A concentration measurement. A microgram is 10-6 grams.
Although not technically correct for fluid measurements, this is sometimes referred to as
ppb (parts per billion)
Nanogram/liter (ng/l): A concentration measurement. A nanogram is 10 -9 grams.
Although not technically correct for fluid measurements, this is sometimes referred to as
ppt (parts per trillion).
NMED: New Mexico Environment Department, collaborating agency for this study
Persistence: A PhACs ability to remain in a detectable pharmaceutically active form in
the environment; a PhAC has high persistence in the aquatic environment if it remains
pharmaceutically active over for a long period of time or through a long course of travel.
PhAC: Pharmaceutically active compound. A compound with pharmaceutical properties
such that it behaves and acts upon target organisms in a manner similar to a
pharmaceutical.
Pharmaceutical: A medicinal drug (http://www.m-w.com/cgi-bin/dictionary)
Photodegradation: See photolysis
Photolysis: The chemical breakdown of a compound or in this case, a PhAC, caused by
sunlight; photodegradation.
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Point source: Sources of PhAC contributions to wastewater or surface water that can be
localized as a specific point. In this study there are five investigated potential point
sources that could contribute PhACs into the wastewater system: the three hospitals and
the two residential sites. The only point source contributor to the Rio Grande is the
SWRP effluent. Non-point source contributors include sources that cannot be localized
such as runoff from an agricultural field. Non-point sources were not addressed by this
study.
Precautionary principle: This is based on the idea that people “must acknowledge
uncertainty is inherent in managing natural resources, recognize it is usually easier to
prevent environmental damage than to repair it later, and shift the burden of proof away
from those advocating protection toward those proposing an action that may be harmful."
(http://www.biotech-info.net/ctw_quote.html).
QAPP: Quality Assurance Project Plan drafted by the NMED for EPA-funded projects
that involve sample collection and analyses. It requires approval by the EPA.
Residential source: A location that contributes PhACs from domestic locations (where
people live, not from industrial, commercial or hospital locations) to wastewater system.
In this study there are two sampling sites that are residential sources: UNM Alvarado
dormitory and Vista del Rio Assisted Living/Retirement Community.
Sexual disruption: In the case of wild fish exposed to PhACs, this refers to fish
developing characteristics/morphology of the opposite sex (male to female and female to
male). In addition to physical characteristics, studies have shown changes in sexual
function such as an inability to reproduce.
SLD: Scientific Laboratory Division, New Mexico Department of Health. Contract
agency for PhAC laboratory analysis.
Sorption: A binding of one compound to another. In the case of PhACs this would be a
PhAC binding to another compound such as clay material or minerals, soil, or activated
sludge. (Huang et al., 2001)
Sulfonamide: A type or sub-classification of antibiotics
Tetracycline: A type or sub-classification of antibiotics.
Transformation: A breakdown of the PhAC structure such that it is no longer
pharmaceutically active.
Transport: the act of remaining mobile within the environment; a PhAC has high
mobility if it remains mobile and is able to move from one environment to another or
along a course of travel (i.e. from hospital effluent through the wastewater treatment
plant and into the river)
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APPENDIX A:
FLOW RATE AND DILUTION CALCULATIONS FOR THE RIO GRANDE AND
SWRP EFFLUENT AT PRESENT AND AFTER CITY OF ALBUQUERQUE SAN
JUAN-CHAMA DIVERSION

Present Flow Rates and Dilution Percentages for SWRP Effluent and the Rio
Grande in Albuquerque, NM
SWRP effluent average flow rate for collection dates 4/8/03-4/10/03
(52.5 mg/d x 1 cfs / .6464 mg/d)

= 52.5 mg/d
= 81 cfs

Rio Grande at Albuquerque flow rate for collection date 3/31/03
(USGS, 2003) (USGS Albuquerque gage is upstream of SWRP)

= 446 cfs

Flow rate of the Rio Grande after the SWRP effluent addition
(446 cfs + 81 cfs)

= 527 cfs

Percentage of flow rate contributed by SWRP effluent
(81 cfs /527 cfs x 100)

= 15.4%

Dilution of SWRP effluent by the Rio Grande
(81 cfs:446 cfs)

= 1:5.5

Predicted Flow Rates and Dilution Percentages for SWRP Effluent and the Rio
Grande in Albuquerque, NM After City of Albuquerque San Juan-Chama
Diversion
The City of Albuquerque is planning to switch from a dependence on ground water to the
predominant use of surface water. To do this, the City of Albuquerque will decrease
ground water pumping and divert 94,000 af/y from the Rio Grande, north of Paseo del
Norte Blvd. in Albuquerque. Although the diversion from the river will be 94,000 af/y,
the City has predicted that, due to hydrologic connections between groundwater and the
Rio Grande, the end result of this 94,000 af/y diversion will actually be a loss of only
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34,000 af/yr in the Rio Grande through the City of Albuquerque. (City of Albuquerque,
2003). Calculations below show 1) the effect of the full 94,000 af/y to show the
maximum potential effect of the diversion if no replacement was gained through aquiferenhanced flow and, 2) the effective diversion of 34,000 af/y as predicted by the City,
based on aquifer-enhanced flow in the Rio Grande due to reduced groundwater pumping.

Calculations are based on the 3/31/03 Rio Grande at Albuquerque flow rate of 446 cfs
(USGS, 2003) and the 4/8/03-4/10/03 average SWRP effluent flow rate of 81 cfs.

Maximum Effect of City of Albuquerque Diversion
(94,000 af/y x 43,560 cf/af)
(4.1x109 cf/y x 1 yr. / 31,536,000 sec)

= 94,000 af/y
= 4.1x109 cf/y
= 128 cfs

Percentage of Rio Grande flow that will be diverted
(128 / 446 x 100)

= 28.9%

Rio Grande at Albuquerque post diversion flow rate
(446 cfs – 128 cfs)

= 318 cfs

Flow rate of the post-diversion Rio Grande after addition of SWRP effluent
(318 cfs + 81 cfs)
= 399 cfs
Percentage of post-diversion flow rate contributed by SWRP effluent
(81 cfs / 399 cfs)

= 20.3%

Maximum dilution of SWRP effluent by the Rio Grande, post diversion
(81 cfs : 318 cfs)

= 1:3.9

City Predicted Effect of City of Albuquerque Diversion

= 34,000 af/y

(34,000 af/y x 43,560 cf/af)
(1.5 x109 cf/y x 1 yr. / 31,536,000 sec)

=1.5 x109 cf/y
= 47 cfs

Percentage of Rio Grande flow that will be diverted
(47/446 x 100)

= 10.5%
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Rio Grande at Albuquerque post diversion flow rate
(446 cfs – 47 cfs)

= 399 cfs

Flow rate of the post-diversion Rio Grande after addition of SWRP effluent
(399 cfs + 81.2 cfs)
= 480 cfs
Percentage of post-diversion flow rate contributed by SWRP effluent
(81.2 cfs / 480 cfs)
Maximum dilution of SWRP effluent by the Rio Grande, post diversion
(81cfs:399 cfs)

= 16.9%
= 1:4.9

It should be noted, that these calculations are based on the 3/31/03 flow of 446 cfs. This
is a relatively low flow. The calculations of percent of flow contribution by SWRP of
15.4%, 20.3 % and 16.9% are only accurate for the Rio Grande flow of 446 cfs. Much of
the year, the flow is greater than this and the percent contribution of the SWRP would be
less. At times, however, the Rio Grande does have even lower flows with a mean low
flow or 4Q3 of approximately 250 cfs. This level was reached several times in 2003. To
address this, during periods of extremely low flow, the City of Albuquerque plans to stop
diversions from the Rio Grande to keep water in the river to maximize dilution of the
SWRP effluent. None the less, the change from ground water pumping to Rio Grande
diversion may reduce Rio Grande flow and consequently, the ability of the Rio Grande to
dilute the SWRP effluent. This could result in the increase of concentrations of PhACs in
the Rio Grande downstream of the SWRP to levels of concern.
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APPENDIX B:
SAMPLE SITE COLLECTION DETAILS AND GENERAL CHEMICAL

05/01

Vista Del Rio

04/07

SWRP
Influent

04/08 –
04/10

SWRP Effluent

04/08 –
04/10

Rio Grande 1 f

03/30

Rio Grande 2 f

03/30

Rio Grande 3 f

03/30

05/07

725

8.6

21.1ºb

850

7.38

9.2º

709

7.7

13.0º

878

varied

3.0º 4.0º

11:15a
0.43

10:00a
2:30p
12:00p

535

7.6

1127
and
1076
813 and
835

6.967.28

e

7.617.83

e

5.6º

330

8.6

.17

3.0º

360

8.41

.18

2.7º

570

8.42

.29

varied
sunny
clear
sunny
clear
sunny
clear

Time of Chemical
Measurements

9.5º

Total Dissolved
Solids (ppt). a

sunny
clear
sunny
clear
sunny
clear
sunny
clear
cloudy

Weather

pH

UNM Dorm

03/31

6:00a 10:00a
6:00a 10:00a
6:00a 10:00a
6:00a 10:00a
6:00a 10:00a
6:00a –
6:00a
(48 hr)
6:00a –
6:00a
(48 hr)
11:50a12:35p
2:15p2:45p
4:30p5:00p

Electrical
Conductance (µ
S/cm)

04/30

Sample Temp.
(Celsius) c

Presbyterian
Hospital
University
Hospital
VA Hospital

Time of
Collection

Sample Site
Location

Collection Date
2003

MEASUREMENTS

a

8:30a
on 4/8d

12:00p
on 3/31
12:00p
on 3/31
12:00p
on 3/31

when this box is blank = instrumentation not available on this date
temperature collected at sample site at 10 am along with chemical measurements using a portable
instrument that was lost and inaccessible for later testing. No ice in ISCO sampler during collection of this
sample.
c
when this box is blank = not collected due to investigator/equipment error. Here, ppt is parts per thousand
d
these chemical measurements were taken at SLD the day after the sample had been delivered, not by the
portable unit, as with the UNM Hospital and not at the Biology Annex Lab as is the case with the other
samples
e
The City of Albuquerque Lab collected the pH and EC measurements around 10 am each day
f
Rio Grande flow as of 4:30 pm on 3/30/03 was 446 cfs (USGS, 2003)
b
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APPENDIX C:
CHEMICAL PROPERTIES AND PHARMACOKINETICS FOR COMMONLY
DETECTED ANTIBIOTICS

Trimethoprim/Sulfamethoxazole
http://www.aegis.com/factshts/network/access/drugs/sulfame.html
http://www.aegis.com/factshts/network/access/drugs/tmp.html

Brand Names: Bactrim, Septra. When administered alone, sulfamethoxazole brand
names include Gantanol and Urobak
Excretion Percentage: The free forms of sulfamethoxazole/trimethoprim are considered
to be the therapeutically active forms. The average percentage of the dose recovered in
urine from 0 to 72 hours after a single oral dose of sulfamethoxazole/trimethoprim is
84.5% for total sulfonamide and 66.8% for free trimethoprim. Thirty percent of the total
sulfonamide is excreted as free sulfamethoxazole, with the remaining as N4-acetylated
metabolite. When administered together as sulfamethoxazole/trimethoprim, neither
sulfamethoxazole nor trimethoprim affects the urinary excretion pattern of the other.
Applications: To treat common respiratory infections, and is also prescribed to people
who have sinusitis. Bactrim is used for prevention and treatment of PCP pneumonia,
particularly in patients with HIV. As a single drug product, sulfamethoxazole is most
commonly used to treat urinary tract infections.
Pharmacokinetics: Both sulfamethoxazole and trimethoprim exist in the blood as
unbound, protein-bound and metabolized forms; sulfamethoxazole also exists as the
conjugated form. The metabolism of sulfamethoxazole occurs predominately by N4acetylation, although the glucuronide conjugate has been identified. The principal
metabolites of trimethoprim are the 1- and 3-oxides and the 3'- and 4'-hydroxy
derivatives. The free forms of sulfamethoxazole/trimethoprim are considered to be the
therapeutically active forms.
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Ciprofloxacin
http://www.rxlist.com/cgi/generic/cipro_cp.htm

Excretion Percentage: Approximately 40 to 50% of an orally administered dose is
excreted in the urine as unchanged drug. Approximately 20 to 35% of an oral dose is
recovered from the feces within 5 days after dosing. Four metabolites have been
identified in human urine which together account for approximately 15% of an oral dose.
The metabolites have antimicrobial activity, but are less active than unchanged. After
intravenous administration, approximately 50% to 70% of the dose is excreted in the
urine as unchanged drug.
Molecular Weight: 331.4
Chemical Formula: C(17)H(18)FN(3)O(3)
Ciprofloxacin is 1-cyclopropyl-6-fluoro-1, 4-drhydro-4-oxo-7-(1-piperazinyl)-3quinolinecarboxylic acid
Ciprofloxacin differs from other quinolones in that it has a fluorine atom at the 6position, a piperazine moiety at the 7-position, and a cyclopropyl ring at the 1-position.
Pharmacokinetics: It is soluble in dilute (0 1N) hydrochloric acid and is practically
insoluble in water and ethanol. The serum elimination half-life in subjects with normal
renal function is approximately 4 hours. After a 250-mg oral dose, urine concentrations
of ciprofloxacin usually exceed 200 mg/ml during the first two hours and are
approximately 30 mg/ml at 8 to 12 hours after dosing. The urinary excretion of
ciprofloxacin is virtually complete within 24 hours after dosing.
Concurrent administration of antacids containing magnesium hydroxide or aluminum
hydroxide may reduce the bioavailability of ciprofloxacin by as much as 90%.
Following a 200-mg I.V. dose, concentrations in the urine usually exceed 200 mcg/ml 0-2
hours after dosing and are generally greater than 16 mcg/ml 8-12 hours after dosing.
Following a 400-mg I.V. dose, urine concentrations generally exceed 400 mcg/ml 0-2
hours after dosing and are usually greater than 30 mcg/ml 8-12 hours after dosing. The
renal clearance is approximately 22 L/hr. The urinary excretion of ciprofloxacin is
virtually complete by 24 hours after dosing. After I.V. administration, three metabolites
of ciprofloxacin have been identified in human urine which together account for
approximately 10% of the intravenous dose.
The bactericidal action of ciprofloxacin results from interference with the enzyme DNA
gyrase which is needed for the synthesis of bacterial DNA.
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Ofloxacin
http://www.rxlist.com/cgi/generic/oflox.htm
http://www.rxlist.com/cgi/generic/oflox_cp.htm

Brand Names: Floxin
Excretion Percentages: Ofloxacin has a pyridobenzoxazine ring that appears to decrease
the extent of parent compound metabolism. Between 65% and 80% of an administered
oral dose of ofloxacin is excreted unchanged via the kidneys within 48 hours of dosing.
Studies indicate that <5% of an administered dose is recovered in the urine as the
desmethyl or N- oxide metabolites. Four to eight percent of an ofloxacin dose is excreted
in the feces.
Molecular Weight: 361.4.
Chemical Formula: C(18)H(20)FN(3)O(4)
Clinical Pharmacology:
Chemically, ofloxacin, a fluorinated carboxyquinolone, is the racemate, (±)-9- fluoro-2,3dihydro-3-methyl-10- (4-methyl-1-piperazinyl)-7-oxo-7H- pyrido[1,2,3-de]-1,4benzoxazine -6- carboxylic acid. Ofloxacin is an off-white to pale yellow crystalline
powder. The molecule exists as a zwitterion at the pH conditions in the small intestine.
The relative solubility characteristics of ofloxacin at room temperature, as defined by
USP nomenclature, indicate that ofloxacin is considered to be soluble in aqueous
solutions with pH between 2 and 5. It is sparingly to slightly soluble in aqueous solutions
with pH 7 and freely soluble in aqueous solutions with pH above 9. Ofloxacin has the
potential to form stable coordination compounds with many metal ions. This in vitro
chelation potential has the following formation order: Fe+3 > Al+3 > Cu+2 > Ni+2>
Pb+2 > Zn+2 > Mg+2> Ca+2 > Ba+2.
Applications: Floxin Tablets and IV are synthetic broad-spectrum antimicrobial agents
for oral or intravenous administration.
Pharmacokinetics: Following oral administration, the bioavailability of ofloxacin in the
tablet formulation is approximately 98%. Maximum serum concentrations are achieved
one to two hours after an oral dose. Absorption of ofloxacin after single or multiple doses
of 200 to 400 mg is predictable, and the amount of drug absorbed increases
proportionately with the dose.
Ofloxacin has biphasic elimination. Following multiple oral doses at steady-state
administration, the half-lives are approximately 4-5 hours and 20-25 hours. However, the
longer half-life represents less than 5% of the total. Accumulation at steady-state can be
estimated using a half-life of 9 hours. The total clearance and volume of distribution are
approximately similar after single or multiple doses. Elimination is mainly by renal
excretion.
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APPENDIX D:
FATE, TRANSPORT, AND PERSISTENCE OF PHARMACEUTICALLY
ACTIVE COMPOUNDS
Antibiotic Class
Sulfonamide

Persistence
High 1

Factors Affecting Fate and Transport
Moderate to weak adsorption to soils 1

Fluoroquinolone

High if sunlight
absent 1

Moderate adsorption to soils 1
Substantial adsorption to sewage sludge 2
With 15-20 hours residence time in river,
concentrations of ciprofloxacin and norfloxacin were
reduced by 66% and 28% respectively 2

Macrolide

Moderate 1

Moderate adsorption to soils 1

Tetracycline

High if sunlight
absent 1

High adsorption to soils; generally low transport 1
Oxytetracycline strongly interacts with clay affecting
its mobility and bioavailability; However, when
competing solutes are present, this binding will be
reduced and the bioavailability and mobility of
oxytetracycline will be affected 3
Sensitive to transformation via photolysis 1
Resists degradation via conventional wastewater
treatment 4

B-Lactam
Trimethoprimother
Penicillin

Low 1

Complexes with metals making Solid Phase
Extraction (SPE) difficult 5
Weak adsorption to soils 1
Trimethoprim reduced to below detection limits by
conventional drinking water treatment plant 6
Penicillin G requires acidic condition for optimum
SPE recovery 5
Easily degrade in the environment 2

1 = Huang et al., 2003
2 = Alder et al., 2003
3 = McKay et al., 2003
4 = Kulis, personal communication, unreferenced, 2003
5 = Chapman, personal communication, unreferenced, 2003
6 = Stackelberg et al., 2003
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